St. Elizabeth's Medical Center

Medivation, Inc.

Selena Pharmaceuticals, Inc.

Sergei O Bachurin

Nikolai Serafimovich Zefirov

Elizaveta E Bukatina

Valery P Chetverikov

Svetlana V Afanasieva

Sergei E Tkachenko

Irina V Grigorieva

Andrei Z Afanasiev

Marina A Jurovskaya

Gregory F Oxenkrug

Pura J Requintina

Vladimir V Grigoriev

Vladmir V Grigoriev

Andrey Zakharovic Afanasiev

Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein Ris Me, Et or PhCH; Ris H, PhCHor 6-Me-3-Py-(CH); and Ris H, Me or Br. The solid line accompanied by the dotted line i.e. represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.

Agents for treating neurodegenerative disorders

This invention relates to the use of N-acetyl-serotonin (NAS) derivatives for the treatment and prophylaxis of neurological injury and neurodegenerative disorders in a mammal.

Method of treating neurodegenerative disorders

Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I):

Agent for treating neurodegenerative disorders

Growing community of inventors

Chernogolovka, Russia

Sergei O Bachurin